Hours

Minutes

Seconds

-40%

on all subscriptions*

Last days

Enjoy this offer

* See conditions under "Our services"

Latest news : BlinkLab Limited

05-19	BlinkLab Enters Academic Research Agreement With Dutch Research Center	MT
04-16	BlinkLab Generates Nearly AU$18 Million From Share Placement; Shares Down 3%	MT
04-16	BlinkLab secures A$17.5m to launch autism diagnostic aid	RE
04-04	3,000,000 Performance Rights of BlinkLab Limited are subject to a Lock-Up Agreement Ending on 4-APR-2026.	CI
04-04	35,000,000 Options of BlinkLab Limited are subject to a Lock-Up Agreement Ending on 4-APR-2026.	CI
04-04	37,913,846 Ordinary Shares of BlinkLab Limited are subject to a Lock-Up Agreement Ending on 4-APR-2026.	CI
03-24	BlinkLab Launches Pivotal US FDA Trial For AI Smartphone Autism Diagnostic Platform BlinkLab Dx1	CI
03-24	BlinkLab Begins Validation Program For Autism Diagnostic Aid	MT
03-23	BlinkLab Says Autism Test Integrated Into Morocco's Nationwide Autism Screening Program, Shares Fall 4%	MT
03-19	BlinkLab requests trading halt pending national Autism Screening Program announcement	RE
03-13	BlinkLab Partners With US-Based Non-Profit Organization; Shares Up 3%	MT
02-25	BlinkLab Limited Reports Earnings Results for the Half Year Ended December 31, 2025	CI
02-12	BlinkLab Adds Clinical Site For Autism Diagnostic Test Pivotal US Regulatory Trial, Shares Fall 4%	MT

More news

Managers and Directors: BlinkLab Limited

Manager	Title	Age	Since
Sebastiaan Koekkoek CTO	Chief Tech/Sci/R&D Officer	-	17/08/2021
Cornelis Boele CTO	Chief Tech/Sci/R&D Officer	-	17/08/2021
Sam Wang PRN	Corporate Officer/Principal	-	17/08/2021

Director	Title	Age	Since
Hendrikus Boele BRD	Director/Board Member	-	18/12/2025
Anton Uvarov BRD	Director/Board Member	-	17/08/2021
Brian Leedman CHM	Chairman	-	15/12/2023

More insiders

BlinkLab Limited is an Australia-based digital healthcare company focused on Artificial intelligence (AI) powered diagnostics. The Company has fully developed a smartphone based diagnostic platform for autism, Attention-Deficit/Hyperactivity Disorder (ADHD), schizophrenia, and other neurodevelopmental conditions. Its product is an autism diagnostic test that leverages the power of smartphones, AI and machine learning to deliver screening tests specifically designed for children as young as over 18 months old. Its pipeline includes BlinkLab Dx 1 and BlinkLab Dx N. Its BlinkLab Dx 1 is an autism diagnostic adjunct. Its BlinkLab Dx N is an ADHD diagnostic adjunct.

Employees

Sector

Software

More about the company

Quotes

Date	Price	Change	Volume
12/06/26	0.6350 $	+6.72%	97,781
11/06/26	0.5950 $	+0.85%	114,433
10/06/26	0.5900 $	+1.72%	314,216
09/06/26	0.5800 $	-6.45%	205,100
05/06/26	0.6200 $	-1.59%	66,421

Delayed Quote Australian S.E.

More quotes

Income Statement and Estimates

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.6350AUD

Average target price

1.830AUD

Spread / Average Target

+188.19%

Consensus

EPS Estimates

Revisions to estimates

Annual profits - Rate of surprise

Company calendar

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Market Closed - Australian S.E. Other stock markets 05:25:02 12/06/2026 +03			5-day change	1st Jan Change
0.6350 ^AUD	+6.72%		+2.42%	-21.60%

Market Cap	97.07M 68.47M 59.14M 54.49M 51.01M 95.59M 6.51B 643M 251M 3.17B 257M 251M 10.97B	P/E Ratio 2026 *	-6.35x	P/E Ratio 2027 *	-6.35x
Enterprise Value	93.07M 65.65M 56.7M 52.25M 48.91M 91.66M 6.24B 617M 241M 3.04B 246M 241M 10.52B	EV / Sales 2026 *	286x	EV / Sales 2027 *	628x
Free-Float	80.71%	Yield 2026 *	-	Yield 2027 *	-

1 day	+6.72%
1 week	+2.42%
Current month	-3.79%
1 month	-3.79%
3 months	-26.16%
6 months	-31.72%
Current year	-21.60%

1 week	0.57	0.64
1 month	0.57	0.72
Current year	0.57	1.07
1 year	0.4	1.1
3 years	0.2	1.1
5 years	0.2	1.1
10 years	0.2	1.1

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
BLINKLAB LIMITED	+6.72%	+2.42%	+39.56%	-	68.47M
MICROSOFT CORPORATION	+0.10%	-6.22%	-17.73%	+16.89%	2,903B
PALANTIR TECHNOLOGIES INC.	-2.36%	-5.56%	-6.85%	+699.94%	307B
CAMBRICON TECHNOLOGIES CORPORATION LIMITED	+1.68%	-4.56%	+205.44%	+693.30%	115B
CADENCE DESIGN SYSTEMS, INC.	+0.32%	+2.33%	+28.32%	+61.07%	106B
SYNOPSYS, INC.	-0.53%	-2.36%	-5.21%	+0.87%	86.91B
DATADOG, INC.	-1.85%	-1.80%	+90.87%	+135.19%	81.84B
SEA LIMITED	-3.21%	-4.18%	-46.28%	+26.24%	50.8B
TAKE-TWO INTERACTIVE SOFTWARE, INC.	-0.16%	-1.23%	-8.03%	+55.16%	39.31B
ROBLOX CORPORATION	-0.41%	+3.56%	-55.43%	+7.52%	31.01B
Average	+0.03%	-1.39%	+22.47%	+188.46%	372.07B
Weighted average by Cap.	-0.16%	-5.41%	-6.53%	+98.09%

BlinkLab Limited Stock

Stocks

BB1

AU0000322851

Software

Valuation: BlinkLab Limited

Chart: BlinkLab Limited

Latest news : BlinkLab Limited

Quotes and Performance

Course Extremes

Managers and Directors: BlinkLab Limited

Other Software

Financials

Company Profile

Quotes

Income Statement and Estimates

Analysts' Consensus

Annual profits - Rate of surprise

	2026 *	2027 *
Net sales	325K 229K 198K 182K 171K 320K 21.79M 2.15M 840K 10.61M 860K 842K 36.72M	145K 102K 88.33K 81.4K 76.19K 143K 9.72M 961K 375K 4.73M 384K 376K 16.38M
Net income	-6.05M -4.27M -3.69M -3.4M -3.18M -5.96M -406M -40.1M -15.64M -197M -16.01M -15.67M -684M	-7.4M -5.22M -4.51M -4.15M -3.89M -7.29M -496M -49.05M -19.12M -241M -19.59M -19.17M -836M
Net Debt	-4M -2.82M -2.44M -2.25M -2.1M -3.94M -268M -26.51M -10.34M -131M -10.59M -10.36M -452M	-6M -4.23M -3.66M -3.37M -3.15M -5.91M -402M -39.77M -15.51M -196M -15.88M -15.54M -678M